NCT05838638

Brief Summary

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
610

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Jun 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Jun 2023Jun 2027

First Submitted

Initial submission to the registry

April 20, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

June 9, 2023

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

May 1, 2026

Status Verified

May 1, 2025

Enrollment Period

4.1 years

First QC Date

April 20, 2023

Last Update Submit

April 27, 2026

Conditions

Keywords

ageddigital technologynauseaneoplasmDrug related side effects and adverse reactionsself-management

Outcome Measures

Primary Outcomes (2)

  • Healthcare resource use

    any emergency department or hospital admission will be recorded using a dichotomous variable (yes/no)

    From baseline through the end of the study at 12 or 24 weeks

  • CINV severity

    The Symptom Management Checklist will measure the presence and severity of nausea and vomiting. Participants will be sent a text link every day for 6 days after chemotherapy or complete this data on a form at home. This starts right after time 1. Nausea will be reported on a 0-10 scale. Higher numbers equal more nausea.

    From baseline1 through the end of the study at 12 or 24 weeks

Secondary Outcomes (4)

  • Self-management behaviors

    From baseline through the end of the study at 12 or 24 weeks

  • Symptom severity

    Baseline and 12 or 24 weeks

  • Cognitive representation

    Baseline and 12 or 24 weeks

  • Health-related Quality of Life

    baseline, 4,8,12,16,20, and 24 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

This intervention is a serious game which allows older adults under treatment for cancer to practice making self-care decisions for an avatar that is being sent home after their first chemotherapy treatment. This serious game is coupled with a discussion with the research assistant about choices related to managing nausea and vomiting at home

Behavioral: eSSET-CINV

Control

ACTIVE COMPARATOR

The control group will receive standard education related to managing nausea and vomiting and will have the opportunity to participate in the intervention at the end of the study

Behavioral: eSSET-CINV

Interventions

eSSET-CINVBEHAVIORAL

Participants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit. The control group will be able to play at time 6.

Also known as: Managing at Home- CINV
ControlIntervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 60 or older
  • newly diagnosed with cancer
  • treatment with any chemotherapeutic agent of moderate or high emetic potential
  • on a 2, 3 or 4 week treatment cycle
  • proficient in English
  • has a telephone

You may not qualify if:

  • previous diagnosis and/or treatment for cancer
  • end stage disease with less than 6 months to live
  • visually or hearing impaired without corrective device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Miller School of Medicine Sylvester Comp. Cancer Center

Miami, Florida, 33136, United States

RECRUITING

Orlando Health

Orlando, Florida, 32806, United States

RECRUITING

Related Publications (5)

  • Loerzel V. Cognitive Representation of Treatment-Related Symptoms in Older Adults With Cancer. Cancer Nurs. 2017 May/Jun;40(3):230-236. doi: 10.1097/NCC.0000000000000395.

    PMID: 27271365BACKGROUND
  • Loerzel V, Clochesy J, Geddie P. Using a community advisory board to develop a serious game for older adults undergoing treatment for cancer. Appl Nurs Res. 2018 Feb;39:207-210. doi: 10.1016/j.apnr.2017.11.030. Epub 2017 Nov 21.

    PMID: 29422160BACKGROUND
  • Loerzel VW, Hines RB, Deatrick CW, Geddie PI, Clochesy JM. Unplanned emergency department visits and hospital admissions of older adults under treatment for cancer in the ambulatory/community setting. Support Care Cancer. 2021 Dec;29(12):7525-7533. doi: 10.1007/s00520-021-06338-y. Epub 2021 Jun 9.

    PMID: 34105026BACKGROUND
  • Wochna Loerzel V, Clochesy JM, Geddie PI. Using Serious Games to Increase Prevention and Self-Management of Chemotherapy-Induced Nausea and Vomiting in Older Adults With Cancer. Oncol Nurs Forum. 2020 Sep 1;47(5):567-576. doi: 10.1188/20.ONF.567-576.

    PMID: 32830802BACKGROUND
  • Loerzel V, Alamian A, Clochesy J, Geddie PI. Serious Gaming for Chemotherapy-Induced Nausea and Vomiting in Older Adults With Cancer: Protocol for a Randomized Clinical Trial. JMIR Res Protoc. 2024 Oct 2;13:e64673. doi: 10.2196/64673.

MeSH Terms

Conditions

NeoplasmsVomitingNauseaDrug-Related Side Effects and Adverse Reactions

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsChemically-Induced Disorders

Study Officials

  • Victoria Loerzel, PhD

    University of Central Florida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Victoria Loerzel, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either an intervention or control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2023

First Posted

May 1, 2023

Study Start

June 9, 2023

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

May 1, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations